9 Retinitis Pigmentosa Clinical Trials in New York, NY (2026)

Q: How do I join a clinical trial in New York?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you.

Recruiting Retinitis Pigmentosa Studies in New York

NCT01561157Recruiting

Longitudinal Study of the Porphyrias

The objective of this protocol is to conduct a longitudinal multidisciplinary investigation of the human porphyrias including the natural history, morbidity, pregnancy outcomes, and mortality in peopl...

New York, NY1,500 participantsThe American Porphyrias Expert Collaborative

View Study Details

NCT01376024Recruiting

Study on Basal Joint Arthritis Prospective

The data in this prospective registry will be used 1) to define which surgical and nonoperative techniques are most effective at providing pain relief, restoring function, are cost effective, and pati...

New York, NY800 participantsColumbia University

View Study Details

NCT05005975Recruiting

Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

To evaluate the long-term safety and tolerability of oral dersimelagon....

New York, NY301 participantsMitsubishi Tanabe Pharma America Inc.

View Study Details

NCT07285694Recruiting

AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC)

This is a multi-center, open-label Phase 1/2 trial evaluating the safety and efficacy of AB-3028 in subjects with metastatic castration resistant prostate cancer (mCRPC)....

New York, NY190 participantsArsenal Biosciences, Inc.

View Study Details

NCT06458712Recruiting

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

Open label, multi-centre, Phase Ia/b adaptive design study with an initial 2-stage Dose Escalation Phase followed by a Dose Expansion Phase....

New York, NY180 participantsDuke Street Bio Ltd

View Study Details

NCT05502133Recruiting

Identification of Acute Intermittent Porphyria Modifying Genes

This study proposes to identify the predisposing/protective modifying genes that underlie the acute attacks in symptomatic patients with Acute Intermittent Porphyria (AIP), an autosomal dominant inbor...

New York, NY150 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT04883905Recruiting

ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)

This global patient registry is being conducted to characterize the natural history and real-world clinical management of patients with AHP, and to further characterize the real-world safety and effec...

New York, NY150 participantsAlnylam Pharmaceuticals

View Study Details

NCT05489393Recruiting

CureDRPLA Global Patient Registry

The objective of the CureDRPLA Global Patient Registry is to establish a longitudinal database of patient-reported data on individuals affected with Dentatorubral-pallidoluysian atrophy (DRPLA) from a...

New York, NY100 participantsCureDRPLA

View Study Details

NCT06646029Recruiting

Pilot Study on The Effectiveness of Relative Motion Orthosis in Finger Motion

The purpose of this feasibility pilot study is to determine the effectiveness of Relative Motion Orthosis (RMO) in regaining finger range of motion compared to standard care in patients diagnosed with...

New York, NY64 participantsNYU Langone Health

View Study Details

About Retinitis Pigmentosa Clinical Trials in New York

Retinitis pigmentosa (RP) is a group of inherited retinal diseases that cause progressive loss of photoreceptor cells in the retina, leading to vision loss. It typically begins with night blindness and progresses to tunnel vision. Gene therapy and retinal implants are areas of active research.

There are currently 9 retinitis pigmentosa clinical trials recruiting participants in New York, NY. These studies are seeking a combined 3,435 participants. Research is being sponsored by The American Porphyrias Expert Collaborative, Columbia University, Mitsubishi Tanabe Pharma America Inc. and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Retinitis Pigmentosa Clinical Trials in New York — FAQ

Are there retinitis pigmentosa clinical trials in New York?

Yes, there are 9 retinitis pigmentosa clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New York?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.

Are clinical trials in New York free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.

What retinitis pigmentosa treatments are being tested?

The 9 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for retinitis pigmentosa.

Data updated July 13, 2026 from ClinicalTrials.gov